Combination of antagonists of growth hormone-releasing hormone antagonist (GHRH) with rapamycin as a potential therapy in human breast cancers.

被引:0
|
作者
Buchholz, S.
Weber, F.
Schally, A.
Ortmann, O.
Seitz, S.
机构
[1] Univ Med Ctr Regensburg, Regensburg, Germany
[2] Univ Miami, Miami, FL USA
[3] Miami Vet Affairs Hosp, Miami, FL USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.e13627
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13627
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone
    Chatzistamou, I
    Schally, AV
    Varga, JL
    Groot, K
    Busto, R
    Armatis, P
    Halmos, G
    ANTI-CANCER DRUGS, 2001, 12 (09) : 761 - 768
  • [32] The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH
    Gaylinn, BD
    Dealmeida, VI
    Lyons, CE
    Wu, KC
    Mayo, KE
    Thorner, MO
    ENDOCRINOLOGY, 1999, 140 (11) : 5066 - 5074
  • [33] Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel
    Buchholz, Stefan
    Schally, Andrew V.
    Engel, Joerg B.
    Hohla, Florian
    Heinrich, Elmar
    Koester, Frank
    Varga, Jozsef L.
    Halmos, Gabor
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (06) : 1943 - 1946
  • [34] Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone
    Engel, JB
    Keller, G
    Schally, AV
    Toller, GL
    Groot, K
    Havt, A
    Armatis, P
    Zarandi, M
    Varga, JL
    Halmos, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06): : 3614 - 3621
  • [35] A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding
    McElvaine, AT
    Mayo, KE
    ENDOCRINOLOGY, 2006, 147 (04) : 1884 - 1894
  • [36] Growth hormone-releasing hormone (GHRH) and GHRH receptor (GHRH-R) isoform expression in ectopic acromegaly
    Othman, NH
    Ezzat, S
    Kovacs, K
    Horvath, E
    Poulin, E
    Smyth, HS
    Asa, SL
    CLINICAL ENDOCRINOLOGY, 2001, 55 (01) : 135 - 140
  • [37] Cellular distribution of growth hormone-releasing hormone receptor in human reproductive system and breast and prostate cancers
    Gallego, R
    Pintos, E
    García-Caballero, T
    Raghay, K
    Boulanger, L
    Beiras, A
    Gaudreau, P
    Morel, G
    HISTOLOGY AND HISTOPATHOLOGY, 2005, 20 (03) : 697 - 706
  • [38] Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists
    Kiaris, H
    Koutsilieris, M
    Kalofoutis, A
    Schally, AV
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (08) : 1385 - 1394
  • [39] Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia Shrinkage
    Rick, Ferenc G.
    Szalontay, Luca
    Schally, Andrew V.
    Block, Norman L.
    Nadji, Mehrdad
    Szepeshazi, Karoly
    Vidaurre, Irving
    Zarandi, Marta
    Kovacs, Magdolna
    Rekasi, Zoltan
    JOURNAL OF UROLOGY, 2012, 187 (04): : 1498 - 1504
  • [40] Growth hormone-releasing hormone receptor (GHRH-R) and its signaling
    Halmos, Gabor
    Szabo, Zsuzsanna
    Dobos, Nikoletta
    Juhasz, Eva
    Schally, Andrew V.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2025,